ABO血型而非分泌型或Lewis血型影响南非黑人儿童对乙型肝炎疫苗抗体应答强度
研究检测南非黑人婴儿ABO、FUT2和FUT3基因16个多态性及其相关表型与乙肝疫苗抗体应答强度的关联。199名婴儿中83.4%为强应答者,15.6%为弱应答者,1%为无应答者。ABO血型与抗体应答强度显著相关(p=0.002),rs8176747G及B抗原表达与抗体应答降低相关,分泌型和Lewis血型无关联。
要点
- ABO血型与乙肝疫苗抗体应答强度显著相关(p=0.002)。
- rs8176747G及B抗原表达与抗体应答降低相关。
- 分泌型和Lewis血型与乙肝疫苗抗体应答无关联。
核心结论
- 在南非黑人儿童队列中,ABO血型与乙肝疫苗抗体应答强度显著相关(p=0.002),而分泌型和Lewis血型无关联。
研究设计与样本
- 研究检测南非黑人婴儿ABO、FUT2和FUT3基因16个多态性及相关表型与乙肝疫苗抗体应答强度的关联;207人中8人(3.86%)既往感染被排除,余199人纳入分析。
主要发现
- 199名婴儿中83.4%为强应答者(抗-HBs ≥ 100 mIU/ml,中位数973 mIU/ml),15.6%为弱应答者(抗-HBs < 100 mIU/ml,中位数50 mIU/ml),1%为无应答者(抗-HBs < 10 mIU/ml)。
- 弱应答者频率不受性别、出生体重、额外加强剂量使用或来源队列的显著影响。
- ABO血型与乙肝疫苗抗体应答强度显著相关(p = 0.002)。
- rs8176747G的存在及B抗原表达(无论在B血型或AB血型中)与乙肝疫苗抗体应答降低相关。
- 分泌型和Lewis血型与乙肝疫苗抗体应答无关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Subunit vaccines for the Hepatitis B virus (HBV) have greatly reduced the prevalence of infection and morbidity through HBV-related liver cirrhosis and cancer. However, strength of immune response to vaccination varies considerably. While it is known that ABO blood types may influence HBV infection risk, the role of ABO and related blood types in strength of immune response to HBV vaccine has not been investigated. We examined 16 polymorphisms in the ABO, FUT2, and FUT3 genes and their related phenotypes for associations with strength of antibody response to HBV vaccine in Black South African infants. Anti-HBc and anti-HBs antibody levels were measured by CMIA assay 1-3 months after the last dose of HBV vaccine. Prior infection occurred in 8/207 individuals (3.86%) who were removed from further study. Of the remaining 199 individuals, 83.4% individuals were strong responders (anti-HBs ≥ 100 mIU/ml, median 973 mIU/ml), another 15.6% were weak responders (anti-HBs < 100 mIU/ml, median 50 mIU/ml) and 1% were non-responders (anti-HBs < 10 mIU/ml). The frequency of weak responders to HBV vaccine was not significantly affected by sex, birthweight, use of an additional booster dose of vaccine or cohort of origin. We characterised patterns of genetic variation present at the ABO, FUT2 and FUT3 loci by use of MassArray genotyping and used these data to predict ABO, Secretor and Lewis phenotypes. We observed significant association of ABO blood type with strength of antibody response to HBV vaccine in a Black South African cohort (p = 0.002). In particular, presence of rs8176747G and expression of B antigen (whether in B blood type or AB blood type) was associated with decreased antibody response to HBV vaccine. Secretor and Lewis blood types were not associated with antibody response to HBV vaccine. This work increases our understanding of the impact that host genetic variation may have on vaccine immunogenicity.
引用
- Berry A, Kapelus D, Singh P, et al. ABO blood types, but not Secretor or Lewis blood types, influence strength of antibody response to Hepatitis B vaccine in Black South African children. Vaccine. 2023. PMID: 37169653. doi:10.1016/j.vaccine.2023.04.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。